20 mg vial of tirzepatide Starter: 12 Week Dose Titration | Twin Ports Dermatology Microdose Compounded Tirzepatide Weight Management

Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 By Tami Luhby, CNN (CNN) Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027

Constantin-Teodosiu Dumitru

Brain Res Brain Res Rev 24 : 91113

Physician-supervised weight loss that delivers real results New Brunswick patients achieve meaningful, lasting weight loss through individualized, monitored GLP-1 programs with ongoing provider support every step of the way

Trademark Disclosure: Ozempic, Wegovy are registered trademarks of Novo Nordisk A/S and Eli Lilly and Company, respectively

Wegovy will be 50% cheaper, while Ozempic will cost 35% less from January 2027